Patel Rajan S, Low Tsu-Hui H, Gao Kan, O'Brien Christopher J
Sydney Head and Neck Cancer Institute, Sydney Cancer Centre, Royal Prince Alfred Hospital and University of Sydney, New South Wales, Australia.
Laryngoscope. 2007 Apr;117(4):644-7. doi: 10.1097/mlg.0b013e318030acc0.
To analyze the clinical outcome of patients treated surgically for chronic parotid sialadenitis.
A retrospective cohort study of patients whose clinicopathologic information had been collected prospectively onto a dedicated head and neck database.
Between 1987 and 2006, a total of 75 patients had 78 parotidectomies, 17 superficial and 61 near-total, to treat chronic parotid sialadenitis. The clinicopathologic data including treatment morbidity and outcome were analyzed.
Temporary postoperative facial weakness occurred in 26 (33%) patients, and this was permanent, although partial, in one (1%) patient. There was no significant difference (P > .05) in the incidence of temporary facial nerve neuropraxia in the superficial (35%) and near-total parotidectomy (33%) groups. Recurrence of symptoms was noted in two patients who had undergone near-total parotidectomy and none of the patients who had undergone superficial parotidectomy. Chronic parotid sialadenitis was effectively treated in 97% of patients undergoing parotidectomy.
Near-total parotidectomy is a safe and efficacious surgical treatment in the management of patients with debilitating severe chronic parotid sialadenitis.
分析接受手术治疗的慢性腮腺涎腺炎患者的临床结局。
一项回顾性队列研究，研究对象为临床病理信息已前瞻性收集到一个专门的头颈数据库中的患者。
1987年至2006年间，共有75例患者接受了78次腮腺切除术，其中17例为浅叶切除术，61例为近全腮腺切除术，以治疗慢性腮腺涎腺炎。对包括治疗并发症和结局在内的临床病理数据进行了分析。
26例（33%）患者术后出现暂时性面部无力，其中1例（1%）患者的面部无力虽为部分性但为永久性。浅叶腮腺切除术组（35%）和近全腮腺切除术组（33%）的暂时性面神经失用症发生率无显著差异（P>.05）。在接受近全腮腺切除术的患者中有2例出现症状复发，而接受浅叶腮腺切除术的患者中无一例复发。97%接受腮腺切除术的患者的慢性腮腺涎腺炎得到有效治疗。
近全腮腺切除术是治疗严重慢性腮腺涎腺炎患者的一种安全有效的手术方法。
